Gender-Affirming Care for Transgender Inmates in North Carolina Prisons

The Eighth Amendment’s prohibition on cruel and unusual punishments raises significant implications for the provision of health care for offenders in North Carolina state correctional facilities. The Eighth Amendment requires that any policy relating to the treatment of inmates maintains their human dignity. The requirement of maintaining human dignity raises unique considerations regarding the availability of medical care to treat conditions such as gender dysphoria for incarcerated individuals.  

House Bill 805 was passed by the North Carolina legislature over Governor Josh Stein’s veto on July 29, 2025. Among the bill’s provisions is a requirement that no state funds be used to provide gender-affirming care to anyone incarcerated by the North Carolina Department of Adult Corrections (DAC). The language of the legislation does, however, provide an exception for treatments that address “medical complications resulting in imminent harm,” which includes conditions caused by previous gender transition procedures. After bill’s passage, many individuals incarcerated in North Carolina prisons who had been diagnosed with gender dysphoria experienced abrupt stoppages in care, particularly in the administration of hormone therapy.  

Policies on Transgender Inmates in Prison 

The DAC policies on the treatment of transgender inmates require the establishment of a Facility Transgender Accommodation Review Committee (FTARC) in each state prison. The FTARC is intended to serve as a multidisciplinary committee that makes accommodation determinations to address housing placements, therapy and treatment requests, gender-specific clothing items, showering accommodations, and items designed for masculinizing or feminizing personal appearance.  

For a higher level of review, the DAC policy established a Division Transgender Accommodation Review Committee (DTARC) including the DAC’s Medical Director, Chief of Psychiatry, Behavioral Health Director, Director of Rehabilitative Services, and the Prison Rape Elimination Act (PREA) Director. The DTARC provides an opportunity for offenders to appeal decisions from the FTARC and reviews non-routine accommodation requests made by transgender inmates. Notably, the DTARC is tasked with reviewing all requests for surgical procedures or “gender-identity-consistent facility transfer.”  

Gender Affirming Care after H.B. 805 

The DAC’s chief medical officer, Arthur Campbell, instructed that transgender inmates currently prescribed hormone therapy be re-evaluated for renewal to determine whether “medical complications resulting in imminent physical harm” would follow from discontinuation. New requests for hormone therapy would have to be made by the primary care practitioner after evaluation of the offender, and the requests would be reviewed and determined based on the risk of “medical complications resulting in imminent physical harm.” However, this threshold requirement does not account for mental health or long-term physical health when considering whether treatment will be permitted.  

Multiple inmates who were actively receiving hormone replacement therapy or had requested gender-affirming surgery were re-evaluated pursuant to H.B. 805, and many had their hormone therapy reduced or discontinued. These alterations in therapy increase the risk of developing long-term health conditions, such as loss of bone density and cardiac complications. Because hormone therapy prescriptions must be renewed periodically, recipients consistently fear further reductions or discontinuations as a result of medically ineffective evaluations to prove the unattainable standard of “imminent physical harm.”  

Ongoing Litigation 

The ACLU of North Carolina and Emancipate NC initiated a lawsuit on behalf of incarcerated individuals diagnosed with gender dysphoria who are unable to access hormone therapy and gender-affirming surgery due to H.B. 805. On March 18, 2026, the parties moved for a preliminary injunction. They argue that the law violates the Eighth Amendment by categorically prohibiting gender-affirming treatment.  

The parties further suggest that the “imminent physical harm” requirement “withhold[s] treatment until a patient’s condition significantly deteriorates,” and that the new barriers to gender-affirming care impose psychological, painful, and dangerous side effects. The motion was filed in the U.S. District Court for the Western District of North Carolina and has yet to be ruled on. 

Kingdom v. Trump 

The issue of transgender access to care in prisons is also being litigated in Kingdom v. Trump. President Trump’s 2025 Executive Order entitled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” included language similar to H.B. 805, declaring a policy that prevents federal funds from being “expended for any medical procedure, treatment, or drug for the purpose of conforming an inmate’s appearance to that of the opposite sex.”  

In February 2026, the Federal Bureau of Prisons (BOP) altered its policy regarding gender dysphoria to require an individualized treatment plan for inmates diagnosed with gender dysphoria, which may include psychotherapy, group counseling, psychiatric services, and psychotropic medications. Additionally, the policy prohibited gender-affirming surgeries and disallowed providing “social accommodations” to address gender dysphoria. Finally, the policy provides that BOP will not provide hormones to inmates and will develop tapering plans for inmates currently prescribed hormone treatment. 

Subsequent to the BOP policy, a group of transgender inmates filed a class action lawsuit to block its enforcement. The District Court judge issued an order barring implementation of the policy, and the Trump administration applied for a stay by the Supreme Court. 

Most recently, on October 21, 2026, the Supreme Court voted 7-2 to deny the application for stay. Although the denial was not accompanied by an opinion explaining the Court’s decision and litigation about the policy will continue, the decision represents a significant win for transgender inmates by requiring BOP to continue to provide gender-affirming care in federal prisons.  

Although the BOP policies set guidelines more extreme than H.B. 805, including restrictions on social accommodations, similarities exist in the restrictions on gender-affirming surgeries and hormone treatment. In North Carolina, this development at the Supreme Court may help give traction to the ongoing litigation by the ACLU and Emancipate NC challenging the validity of H.B. 805. 

Sanya Singh 

Class of 2028, Staff Member